Shortage Of Erwinase For Injection And Replacement With UK Labelled Stock
Erwinase for Injection Recall Summary Erwinase for Injection is in short supply in Canada, and the FDA is allowing the use of UK-labeled stock as a temporary replacement to maintain patient access to this medication. This recall affects all Canadian patients and healthcare providers who use or prescribe Erwinase for Injection.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2018-02-27
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/ec1e007b-345f-4c4b-9faf-b71e75f33bbe